Revvity, Inc. (RVTY)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about Revvity, Inc. (RVTY)
Company Performance

Current Price

as of Dec 02, 2024

$116.70

P/E Ratio

47.42

Market Cap

$14.2B

Description

Revvity, Inc. provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. It focuses on translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, and informatics. With a global network and localized agility, the company serves a diverse range of organizations from pharmaceutical and biotech to clinical labs, academia, and governments. It is headquartered in Waltham, MA.

Metrics

Overview

  • HQWaltham, MA
  • SectorHealth Technology
  • IndustryMedical Specialties
  • TickerRVTY
  • Price$116.7+0.48%

Trading Information

  • Market cap$14.20B
  • Float99.62%
  • Average Daily Volume (1m)1,084,221
  • Average Daily Volume (3m)824,588
  • EPS$2.46

Company

  • Revenue$2.72B
  • Rev growth (1yr)1.98%
  • Net income$93.39M
  • Gross margin56.26%
  • EBITDA margin30.74%
  • EBITDA$210.27M
  • EV$17.59B
  • EV/Revenue6.46
  • P/E47.42
  • P/S5.28
  • P/B1.80